Copy number variation (CNV) is an attractive emerging approach to study the association with various diseases. We performed a CNV-based genome-wide association study of pulmonary function measures (FEV 1 , FVC, and FEV 1 /FVC) in KARE cohorts. Affymetrix Genome-wide Human SNP Array 5.0 was used to measure genome-wide variation and CNV segmentation was performed using Golden Helix SVS 7.0. Single and multivariate regressions were used for the association study using the R statistical package and the Dabatase for Annotation, Visualization and Integrated (DAVID v6.7b) tool for the functional annotation. We identified significantly associated 1260 CNVs with pulmonary function measures of FEV 1 and FVC. Functional gene classification and annotation analysis found 5 highly enriched clusters, the BPI/LBP/Plunc superfamily, myosin, serpin peptidase inhibitor, protein tyrosine phosphatase, and olfactory receptors. According to the functional annotation, gene-based CNVs are likely to be involved in the pathogenesis and inflammatory responsiveness of pulmonary diseases.
Introduction
Pulmonary function measures identify the physiological state of lungs and airways and are important indicators for the diagnosis of pulmonary diseases such as asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis [1] [2] [3] . The forced expiratory volume in the first second (FEV 1 ), the forced vital capacity (FVC), and the ratio of FEV 1 to FVC are measures obtained by spirometry, which is the commonest test of pulmonary function. FEV 1 should be approximately 75-80% of the FVC in healthy adults. In restrictive diseases such as a pulmonary fibrosis, both FEV 1 and FVC are proportionally decreased and the FEV 1 /FVC is normal or increased. In obstructive diseases such as bronchial asthma and COPD, FEV 1 is reduced and FVC is usually normal, which gives a reduced FEV 1 /FVC value. The measures provide indexes to assess disease severity and to monitor the progression of obstructive lung disease over time [2] . Heritability estimates and twin studies have suggested that genetic factors contribute to pulmonary function, at least in part, but few genetic determinants of lung function have been identified [4] [5] [6] [7] [8] . Several genome-wide association studies (GWAS) identified significant single nucleotide polymorphisms (SNP) associated with pulmonary function measures in case-control or cohort populations [9] [10] [11] [12] . Genetic association studies with different genetic variants in the genes of interest have been used to verify the association of the genes with pulmonary function [13] [14] [15] [16] .
In the past few years, efforts have been made to investigate the potential effects of copy number variation (CNV) on human health and disease [17] [18] [19] [20] . Both CNV and SNP were used to identify the association with phenotype variation or susceptibility or resistance to diseases. CNV encompasses more DNA than SNP and contains entire genes and their regulatory region [21] . In addition to deletion and duplication rearrangements, structural variants can alter transcription of genes by changing the copy number of genes sensitive to a dosage effect or by disrupting proximal or distant regulatory regions [22, 23] . In terms of CNV, genome-wide association studies and the candidate region approach are growing fast and the statistical algorithms to call CNV are improving. Few genome-wide studies have identified the association of CNV with common complex traits, including autism, schizophrenia, and obesity in case-control studies [18] [19] [20] .
In this study, we found CNVs associated with the pulmonary function (FEV 1 , FVC, and FEV 1 /FVC) on a genome-wide scale using large unrelated healthy adult populations of Korea Associated Resource (KARE). The cohort data have been applied to GWAS of SNP for 8 biomedically important quantitative traits and used to survey CNVs in an East Asian population [24, 25] . This study is, to our knowledge, the first CNV-based genome-wide association study with KARE cohorts and it is focused on the dosage effect of genes included in the CNVs identified as significant for pulmonary function.
Results

Discovery of CNVs associated with pulmonary function measures
From the KARE cohort populations, we extracted a total of 10,534 regions of the CNV by the multivariate segmenting option provided by Golden Helix SVS 7.0. Single-CNVR regression analysis identified 1688 CNVs with 3402 intact genes for FVC_%PRED and 720 CNVs with 2122 for FEV 1 _%PRED at the p value of b0.05 after Bonferroni correction (Supplementary figure S1). However, no significant CNV was found for FEV 1 /FVC_PRED. FEV 1 and FVC were highly correlated (correlation value of 0.81), and we performed multivariate analysis for both phenotypes and found 1260 significant CNVs (Supplementary table S1). A summary of CNVs associated with the pulmonary function measures is given in Table 1 . The total size of significant CNVs was 499 Mb, which occupied about 16% of whole genome. The median size of CNVs was 223 kb (range 7-4985 kb). Based on the criteria of the intensity ratio ±0.4, the number of CNV loss was 6-fold greater than those of CNV gain ( Table 1 ). Out of 1260 CNVs, 675 contained genes intact or in part and 142 CNVs were small enough to be included in a gene. A total of 2385 intact genes were identified in CNVs from the multivariate regression analysis ( Supplementary table S2 ).
Identification of SNP associated with pulmonary function measures
We analyzed the SNPs associated with FEV1 and FVC using PLINK and identified 76 SNPs for FVC and 48 for FEV 1 (p b 0.05). Three genes (CENPC1, GNPDA2, and ZIC4) were in common with the CNV result. Out of those SNPs, 19 SNPs for FVC and 10 for FEV 1 were reached the threshold for genome-wide statistical significance (p b 5 × 10 − 08 ) ( Supplementary table S4 ). The genomic control values (λ gc ) were 1.043 and 1.048 for FEV 1 and FVC, respectively, and Q-Q plots of the results were presented in Supplementary figure S3. Among these SNP identified, one SNP (rs10935655) was located in the one of CNV regions associated with FEV 1 and FVC. The CNV region contains two genes ZIC1 and ZIC4 on chromosome3 and the SNP (rs10935655) was located about 260 kb upstream of ZIC4. None have reported that ZIC4 (Zic family member 4) are related to FEV 1 and FVC so far but few studies showed that the presence of ZIC4 antibodies was associated with paraneoplastic cerebellar degeneration (PCD) and small cell lung cancer (SCLC).
Replication of genes associated with pulmonary function measures
Genes associated with the pulmonary function measures and/or pulmonary diseases are in the literature. In this study, we asked whether any of the genes was replicated. In the multivariate analysis, we found 14 genes reported in the literature ( Table 2 ). Twelve genes (IL10, KCNMB1, WISP1, ALOX5AP, TNS1, HTR4, IL4R, TRPV4, CHI3L1, MSR1, CASP10, and CRHR1) were identified as SNP variants near and/ or within each gene that was associated with the pulmonary function measures and pulmonary diseases [14, 15, [26] [27] [28] [29] [30] [31] . Microsatellite polymorphism in HMOX1 has been reported to be associated with FEV 1 and FEV 1 /FVC, and in/del polymorphism in ACE has been reported to be associated with asthma beside FEV 1 and FEV 1 /FVC [32, 33] .
Gene ontology and functional annotation
The DAVID v6.7b tool was used for analyzing the functional annotation of 2384 genes identified by the multivariate regression analysis, and 2163 gene ID were mapped to DAVID ID for analyzing the functional annotation. Gene functional classification clustered genes into 50 groups with highest stringency. Five groups had an enrichment score of N1.3 with a range of 1.4-1.76 (Fig. 1 ). The enrichment groups were BPI/LBP/Plunc superfamily, myosin, serpin peptidase inhibitor, protein tyrosine phosphatase, and olfactory receptors. (Genes enriched in each group are listed in Supplementary  table S3 .) The gene ontology (GO) of biological process was represented by the View of GO tree based on genes with common GO terms (p b 0.01). GO terms involving cell surface receptor-linked signal transduction and Wnt receptor signaling pathway were the most significantly enriched in this analysis. Significant GO identified by cellular component analysis (p b 0.01) was mostly related to muscle components such as myosin and filament and voltage-gated sodium channel complex ( Table 3 ). The most significant KEGG pathway was the olfactory transduction containing 67 genes (p = 0.002).
Discussion
An association study of CNV with complex diseases has become a more attractive field since some CNVs were reported to be associated with various diseases [17] [18] [19] [20] . We identified 1260 CNVs associated with pulmonary function measures of FEV 1 and FVC. This is approximately 16% of the genome in KARE cohorts, which appears to be a little higher than that found in other CNV studies. Yim et al. [25] studied CNV using other samples of the same KARE populations and found that CNV covered 8% of the genome. It seems that the number of CNV regions obtained could vary based on the variation of boundaries among technical or biological sources and different algorithms used for analysis. Especially with the association study between CNVs and diseases, our knowledge of reference human CNV and statistical analysis is still incomplete. However, we found that CNV loss count was 6 times higher than CNV gain, which was similar to an earlier study whose CNV loss count was 4-fold greater than CNV gain [25] .
The validation of our result is to determine whether the genes identified by our analysis showed the consistency of those reported earlier. Most recently, two studies of GWAS for the pulmonary function using SNP have been published, which identified multiple loci associated with the phenotypes [9, 34] . We found 2 genes, HTR4 (P.bon = 2.15E-03) and TNS1 (P.bon = 1.74E-03) in common with CHARGE consortium studies and the SpiroMeta Consortium [9, 34] . However, we do not have any gene in common with the Framingham Heart Study cohorts [11, 12] . It was not surprising that our result had few genes common with the previous SNP-based GWAS considering that different SNP-based GWAS often showed different results based on the statistical methods used for association analysis and the population structure or history. The result of SNP analysis in KARE cohorts showed no common genes with other cohorts mentioned above, even though 3 SNP regions were identified by the CNV-based result. In CNV analysis, deciding CNV boundaries and algorithms for calling CNV regions associated with traits of interest seems to be most important factors that could affect the results. Unlike SNP, statistical analyses for GWAS based on CNV are still developing. Since CNV contains more DNA segment than SNP (≥1kbp), the significant SNP might not be identified by CNV analysis unless other genetic variations were consecutively existed within 1-kb distance around it. In other words, SNP might be only identified where their locations are overlapped within CNV boundaries. In addition to GWAS, we found another 12 genes (IL10, KCNMB1, ALOX5AP, CHI3LI, TRPV4, ADAM33, CASP10, WISP1, MSR1, CRHR1, HMOX1, and ACE) that were reported to be associated with the pulmonary function in association studies of genetic variants in addition to GWAS. Although there is no apparent evidence of direct association with the traits of FEV 1 , FVC, or FVE 1 /FVC, we found some other common genes that are strongly or mildly associated with several pulmonary diseases, such as COPD, asthma, and idiopathic pulmonary fibrosis (IPF). Boon et al. [35] constructed gene expression profiling between progressive and relatively stable IPF by serial analysis of gene expression (SAGE) study. We detected 5 genes (NHLRC2, SRI, NEK4, TAL1, and PLUNC) highly expressed in the progressive group that were characterized based on the changes in FVC (≥ 10%) and DLCO (≥ 15%) over 12 months. Instead of the genes of interest, we often observed a tendency to detect other members in the same family of the genes, which might suggest that other variants of the genes also putatively contribute to the function for the phenotypes and might provide a greater chance to identify a novel gene or gene function related to phenotype. In general, CNV might not have any genes within it or it can contain genes intact and/or in part. For the functional analysis of the CNV-based genes identified, we selected genes intact in the CNVs to focus on the dosage effect of CNV on pulmonary function. Gene Functional Classification by the DAVID tool useful for clustering large gene lists into functionally related groups. The significantly enriched clusters showed that genes identified from the multivariate regression analysis appeared to be related to the pathogenesis and the inflammatory responsiveness of pulmonary diseases. The most highly enriched cluster is the BIP/LBP/Plunc superfamily group. Most genes including PLUNC in this group are located in chromosome 20, which is known to contribute a novel family, the BIP/LBP/Plunc superfamily, and appear to mediate host defense function against bacteria in the oral, nasal, and respiratory epithelia [36, 37] . Levels of sPLUNC1 protein are increased in airway fluid from smokers, from people exposed to irritant chemicals and in sputum from patients with COPD [38] . The second ranked cluster includes genes in the myosin family. Myosin is an important component of airway smooth muscle (ASM) and is involved in smooth muscle contraction and the airway constriction. ASM in human has several functions of asthma pathogenesis. In normal lung, ASM assists in regulation of gas exchange, mucus clearance, defense mechanisms, and coughing, and in the airways of individuals with asthma, the smooth muscle layer becomes thicker as the result of increased cell size and/or cell number [10, 39] . MYH11 is the representative gene of the smooth muscle myosin heavy chain and selective over-expression among its variants contributes to the airway hyper-responsiveness in asthma [40, 41] . Tyrosine phosphorylation is related to the permeability of lung epithelium. Cigarette smoke is known to increase the permeability of the lung epithelium, which results in the access of toxins and pathogens. Mainstream cigarette smoke exposure increased tyrosine phosphorylation of occludin but not ZO-1 and decreased association between the two tight junction proteins [42] . Numerous studies have demonstrated that the imbalance between the serin proteases and serine protease inhibitors (SERPINs) is involved in the pathogenesis of COPD [43] [44] [45] . There are many members in the SERPIN family and the most widely recognized genes are SERPINA1 and SERPINA3. SERPINA1 is a candidate gene for COPD, but we were not able to detect it in this study. Instead, we found SERPINA3 and other members in this family that have been studied only a little [46, 47] . Zhong et al. [47] suggested that other members of this gene family could be involved in the onset of COPD and deserve further investigation. The least enriched functional classification is olfactory receptor (OR) and G-proteincoupled receptor (GPCR) protein. The human OR gene family is a large multigene family in the genome. These genes basically encode 7 transmembrane-type G-protein-coupled receptors of the cell surface [48] . The gene products are expressed in the olfactory epithelium in the nose and function as the first odorant receptors. OR gene products appear to be involved in cell signaling pathway in addition to odorant receptor pathways. There is no direct functional study of the relationship between OR and lung function, except that nonfunctioning single nucleotide polymorphism in OR4X1 gene was found to be associated with FEV 1 /FVC in an individual of the Yamagata Takahata cohort [49] . The pulmonary function candidate gene, HTR4, mentioned above, belongs to this group. HTR4 is involved in the serotonin signaling pathway, which has been implicated in immunemediated airway reactivity [9] . We identified CNVs significantly associated with the pulmonary function measures of FEV 1 and FVC in KARE cohorts using genome-wide association analysis. CNV-based genes analyzed by functional annotation showed that they were likely to be involved in the pathogenesis and inflammatory responsiveness of pulmonary diseases, although genomewide CNV association study with phenotypes or common disease is still at an early stage and requires more definitive criteria of CNV boundary and statistical algorithms for calling CNV for the more robust analysis.
Materials and methods
Cohort description
This study used the data of cohorts from the KARE project [24, 25] . For CNV analysis, we chose 8842 individuals after QC control of genotyping in the study by Cho et al. [24] . The predicted values for FEV 1 (FEV 1 _% PRED), FVC (FVC_%PRED), and FEV 1 /FVC (FEV 1 /FVC_PRED) from the cohorts were used for the association study of pulmonary function. Out of 8842 subjects, 308 were excluded from the analysis because the phenotypic value or the smoking status was not known. A total of 8535 participants of 39-70 years old were used for the association study and the characteristics of the cohorts are described in Table 4 .
SNP genotyping, quality control, and association analyses
Genotyping data and quality control were performed by Cho et al. [24] . Association analysis was done using PLINK. Linear regression analysis was performed for FEV 1 and FVC with an additive model after adjustment for sex, age, and areas.
CNVR segmentation or defining CNVR
The intensity data of 780,822 SNP and non-polymorphic probes were generated by Affymetrix Genome-wide Human SNP Arrays 5.0 to measure the genome-wide variation of CNV. The CEL file containing the intensity value was imported into Golden Helix SVS 7.0 for the analysis of CNV segmentation and discovery (Golden Helix Inc., Bozeman, MT, USA). In order to normalize the intensity and produce the log2 ratio, we used the mean intensity value of 8842 samples as a reference to minimize the technical variability between chips and locations as much as possible. Multivariate algorithm by copy number analysis module (CNAM) in the Golden Helix SVS 7.0 was used for the segmentation of chromosomes with a moving window size of 5000, maximum segments/window 100, minimum number of markers/segment 10, and a significance level of p b 0.01 for pairwise permutations (n = 1000).
CNV association study of pulmonary function
Boxplot was used to check the distribution of cohort data for the predicted value for FEV 1 , FVC, and FEV 1 /FVC (Supplementary figure S2) . Single linear regression was used to identify CNVs associated with each quantitative trait. For the traits that were correlated to each other, multivariate linear regression analysis was used to detect the regions of CNV with the R software. Both regression models were adjusted for sex, age, area, and smoking status under the additive genetic model. Smoking status was classified into non-smoker, ex-smoker, or smoker. Multiple corrections including the Bonferroni correction and FDR were used for both single and multivariate analysis. Significant CNVs were counted at the normal significance level of (p b 0.05) after Bonferroni correction.
Functional annotation of CNV-based genes
From the CNVs associated with the phenotypes, we collected the genes whose entire sequence was located within a CNV. The genes were annotated using RefGene downloaded from the UCSC genome browser ver.hg18 (http://genome.ucsc.edu/). We used the list of genes resulted from the multivariate analysis for functional analysis. The Database for Annotation, Visualization and Integrated Discovery (DAVID) v6.7b was used for analyzing functional classification, gene ontology, and pathway (http://david.abcc.ncifcrf.gov/) [50] .
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